Literature DB >> 12402301

Estrogen receptor alpha expression in normal human breast epithelium is consistent over time.

Seema A Khan1, Kimberly A Yee, Cassandra Kaplan, Josephine F Siddiqui.   

Abstract

If increased expression of estrogen receptor alpha (ER) in benign breast epithelium increases susceptibility to breast cancer, such overexpression should be stable over time. There are no published data regarding this important aspect of ER expression in breast epithelium. We examined the temporal consistency of ER expression in the normal breast tissue of 28 women who had 2 separate breast surgical procedures, at least 6 months apart (mean interval, 2.8 years). Paraffin embedded breast tissue blocks containing an adequate sample of normal breast epithelium and no cancer, were sectioned and processed using the 6F11 antibody and standard immunohistochemical techniques. The ER labelling index (ER LI) was calculated by counting a mean of 2,000 epithelial cells. The median ER LI at first sampling was 13.6 and at second sample 15.5, with R(2) = 0.34 and p = 0.001. The ER LI was categorized into high and low values, using a threshold of 10. Twenty-four women (85.7%) showed concordance of high and low expression between the 2 samples (p = 0.002). There were 11 women who were premenopausal at both time points. Among them, much of the variation in ER LI was explained by differences in the menstrual cycle day at the time of sampling and adding the day of cycle to the regression model substantially improved the correlation between first and second labeling indices. These data suggest that ER expression of normal breast tissue is fairly consistent over time and support the notion that overexpression of ER in normal epithelium is a constant feature of the high risk breast. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402301     DOI: 10.1002/ijc.10737

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.

Authors:  Jing Xie; Shelley S Tworoger; Adrian A Franke; Kathryn L Terry; Megan S Rice; Bernard A Rosner; Walter C Willett; Susan E Hankinson; A Heather Eliassen
Journal:  Breast Cancer Res Treat       Date:  2013-06-13       Impact factor: 4.872

2.  RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.

Authors:  Viera Kajabova; Bozena Smolkova; Iveta Zmetakova; Katarina Sebova; Tomas Krivulcik; Vladimir Bella; Karol Kajo; Katarina Machalekova; Ivana Fridrichova
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

3.  Expression of Luminal Progenitor Marker CD117 in the Human Breast Gland.

Authors:  Jiyoung Kim; René Villadsen
Journal:  J Histochem Cytochem       Date:  2018-07-13       Impact factor: 2.479

4.  Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics.

Authors:  Joaquin Chapa; Ryan J Bourgo; Geoffrey L Greene; Swati Kulkarni; Gary An
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

5.  Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls.

Authors:  Christy G Woolcott; Sandip K SenGupta; Wedad M Hanna; Kristan J Aronson
Journal:  BMC Cancer       Date:  2008-05-08       Impact factor: 4.430

6.  Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model.

Authors:  Joaquin Chapa; Gary An; Swati A Kulkarni
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

Review 7.  Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast Carcinogenesis.

Authors:  Madalin Marius Margan; Andreea Adriana Jitariu; Anca Maria Cimpean; Cristian Nica; Marius Raica
Journal:  J Breast Cancer       Date:  2016-06-24       Impact factor: 3.588

8.  Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue.

Authors:  Hannah Oh; A Heather Eliassen; Andrew H Beck; Bernard Rosner; Stuart J Schnitt; Laura C Collins; James L Connolly; Laleh Montaser-Kouhsari; Walter C Willett; Rulla M Tamimi
Journal:  NPJ Breast Cancer       Date:  2017-10-02

9.  Association between low estrogen receptor positive breast cancer and staining performance.

Authors:  Dennis Caruana; Wei Wei; Sandra Martinez-Morilla; David L Rimm; Emily S Reisenbichler
Journal:  NPJ Breast Cancer       Date:  2020-02-05

10.  Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.

Authors:  M Raap; L Gierendt; C Werlein; E Kuehnle; H H Kreipe; M Christgen
Journal:  J Mol Histol       Date:  2021-06-11       Impact factor: 2.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.